PureTech Health
PRTC
PRTC was delisted on the 20th of May, 2026.
3 hedge funds and large institutions have $290K invested in PureTech Health in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.03% less ownership
Funds ownership: 0.03% → 0% (-0.03%)
25% less funds holding
Funds holding: 4 → 3 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
84% less capital invested
Capital invested by funds: $1.86M → $290K (-$1.57M)
Top Buyers
| 1 |
PCM
Pentwater Capital Management
Naples,
Florida
|
+$209K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$835 |
Top Sellers
| 1 |
AIC
AWM Investment Company
New York
|
-$1.61M |
| 2 |
Jane Street
New York
|
-$247K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$163 |
PRTC Hedge Fund Activity: Q4 2023 in Review
3 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in PureTech Health (PRTC) for Q4 2023, worth a combined $290K — down 84% from $1.86M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of PRTC and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was Pentwater Capital Management, opening a new position worth an estimated $209K. The largest seller was AWM Investment Company, exiting entirely with an estimated $1.61M sold.
- 3 institutional investors held PureTech Health (PRTC) as of Q4 2023, down from 4 in Q3 2023.
- Funds reported $290K of PureTech Health stock for Q4 2023, down 84% quarter-over-quarter.
- 1 fund opened new PureTech Health positions in Q4 2023 and 2 closed out, a net change of -1 holder.
- The largest PureTech Health buyer in Q4 2023 was Pentwater Capital Management, an estimated $209K added.
- The largest PureTech Health seller in Q4 2023 was AWM Investment Company, an estimated $1.61M sold.
Based on aggregated 13F filings for Q4 2023.